WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Why China Will Capitalize on Groundbreaking Healthcare Solutions Before The West(2/13/2018 )  (Premium)
How Tencent's Medical Ecosystem Is Shaping the Future of China's Healthcare(2/13/2018 )  (Premium)
GSK's Digital Strategies for Reaching New Buyers in China(2/13/2018 )  (Premium)
The Chinese Pharmaceutical Industry: Winners and Losers 2017(2/12/2018 )  (Premium)
Industry News
MOLOGEN Signs Deal with ONCOLOGIE for Lead Compound Lefitolimod(2/13/2018 )  (Premium)
GNC Announces $300M Partnership with Harbin Pharma(2/13/2018 )  (Premium)
India Pharma Companies See Growing Opportunities in China following Regulatory Reform(2/13/2018 )  (Premium)
GC Pharma and Lee's Pharm Enter into China Licensing Agreement for Anticoagulant Candidate(2/13/2018 )  (Premium)
MSD Files NDA for Anticancer Keytruda in China(2/13/2018 )  (Premium)
Regulatory News
CFDA Releases List of Reference Formulations for Generic Drug Equivalence Studies (13th Batch)(2/14/2018 )  (Premium)
CFDA Seeks Comments on Draft Document for Matters Related to Import Drug Registration(2/13/2018 )  (Premium)
CFDA Publishes Its 2018 Legislation Plan(2/12/2018 )  (Premium)
CDE Solicits Comments on the General Requirements on Batch Production Size for Registration of Chemical Generic Drugs(2/12/2018 )  (Premium)
General Health
British Government Announces Healthcare Deals with China Worth Over GBP 500M(2/14/2018 )  (free)
China Reviews Achievements of the BMI System and Medical Assistance Program for the Poor in 2017(2/14/2018 )  (Premium)
Legal/IPR News
UK Investigators Ask for New Info from GSK Relating to Its China Corruption Scandal(2/13/2018 )  (Premium)
Product/R&D News
China's R&D Spending at Record High in 2017(2/14/2018 )  (Premium)
BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients with Urothelial Carcinoma(2/13/2018 )  (Premium)
Chi-Med Enrolls 527 Patients in Pivotal Phase III FALUCA Trial of Fruquintinib in Lung Cancer(2/13/2018 )  (free)
People in the News
Recent Executive Moves(2/15/2018 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links